View Future GrowthIDEX Biometrics 과거 순이익 실적과거 기준 점검 0/6IDEX Biometrics은 연평균 18.6%의 비율로 수입이 증가해 온 반면, Electronic 산업은 연평균 5%의 비율로 증가했습니다. 매출은 연평균 21.9%의 비율로 감소했습니다.핵심 정보18.61%순이익 성장률38.33%주당순이익(EPS) 성장률Electronic 산업 성장률25.59%매출 성장률-21.89%자기자본이익률n/a순이익률-2,934.86%다음 순이익 업데이트20 Aug 2026최근 과거 실적 업데이트Reported Earnings • Mar 05Full year 2025 earnings released: US$0.26 loss per share (vs US$3.49 loss in FY 2024)Full year 2025 results: US$0.26 loss per share (improved from US$3.49 loss in FY 2024). Net loss: US$10.0m (loss narrowed 31% from FY 2024).공시 • Dec 31+ 3 more updatesIDEX Biometrics ASA to Report First Half, 2026 Results on Aug 20, 2026IDEX Biometrics ASA announced that they will report first half, 2026 results on Aug 20, 2026Reported Earnings • Nov 15Third quarter 2025 earnings released: US$0.02 loss per share (vs US$0.43 profit in 3Q 2024)Third quarter 2025 results: US$0.02 loss per share (down from US$0.43 profit in 3Q 2024). Net loss: US$992.0k (down 173% from profit in 3Q 2024).Reported Earnings • Aug 27Second quarter 2025 earnings released: US$0.07 loss per share (vs US$2.29 loss in 2Q 2024)Second quarter 2025 results: US$0.07 loss per share (improved from US$2.29 loss in 2Q 2024). Net loss: US$2.07m (loss narrowed 69% from 2Q 2024).공시 • May 08IDEX Biometrics ASA to Report Q3, 2025 Results on Nov 13, 2025IDEX Biometrics ASA announced that they will report Q3, 2025 results on Nov 13, 2025공시 • Jan 01+ 3 more updatesIDEX Biometrics ASA to Report Q4, 2025 Results on Feb 26, 2026IDEX Biometrics ASA announced that they will report Q4, 2025 results on Feb 26, 2026모든 업데이트 보기Recent updatesBoard Change • Jun 10High number of new directorsExecutive Chairman of the Board Anders Storbraten was the last director to join the board, commencing their role in 2026.공시 • Jun 05IDEX Biometrics ASA has filed a Follow-on Equity Offering in the amount of NOK 20.625 million.IDEX Biometrics ASA has filed a Follow-on Equity Offering in the amount of NOK 20.625 million. Security Name: Shares Security Type: Common Stock Securities Offered: 2,500,000 Price\Range: NOK 8.25 Transaction Features: Subsequent Direct Listing공시 • May 30IDEX Biometrics ASA has withdrawn its Follow-on Equity Offering in the amount of NOK 19.999997 million.IDEX Biometrics ASA has withdrawn its Follow-on Equity Offering in the amount of NOK 19.999997 million. Security Name: Shares Security Type: Common Stock Securities Offered: 2,424,242 Price\Range: NOK 8.25 Transaction Features: Rights Offering공시 • Apr 29IDEX Biometrics ASA has filed a Follow-on Equity Offering in the amount of NOK 19.999997 million.IDEX Biometrics ASA has filed a Follow-on Equity Offering in the amount of NOK 19.999997 million. Security Name: Shares Security Type: Common Stock Securities Offered: 2,424,242 Price\Range: NOK 8.25 Transaction Features: Rights Offering공시 • Mar 06IDEX Biometrics ASA announced that it expects to receive NOK 90.000001 million in fundingIDEX Biometrics ASA announced a private placement to issue NOK 90,000,000 to ID centric in two tranches on March 5, 2026.The first tranche with 3,824,233 new shares at a price of NOK 5.83 per share for gross proceeds of NOK 2,2295,278.39 and it is getting closed on the same day. The second tranche with 11,613,159.795883 at a price of NOK 5.83 per share for gross proceeds of NOK 67,704,721.609998. The first tranche has been approved by the board of directors and an extraordinary general meeting will be held on or about March 27, 2026 to seek the necessary approval for the second tranche.Reported Earnings • Mar 05Full year 2025 earnings released: US$0.26 loss per share (vs US$3.49 loss in FY 2024)Full year 2025 results: US$0.26 loss per share (improved from US$3.49 loss in FY 2024). Net loss: US$10.0m (loss narrowed 31% from FY 2024).공시 • Jan 02IDEX Biometrics ASA, Annual General Meeting, May 21, 2026IDEX Biometrics ASA, Annual General Meeting, May 21, 2026.공시 • Dec 31+ 3 more updatesIDEX Biometrics ASA to Report First Half, 2026 Results on Aug 20, 2026IDEX Biometrics ASA announced that they will report first half, 2026 results on Aug 20, 2026New Risk • Dec 23New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Norwegian stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Shareholders have been substantially diluted in the past year (over 5x increase in shares outstanding). Revenue is less than US$1m (US$209k revenue). Minor Risk Market cap is less than US$100m (kr362.3m market cap, or US$36.0m).공시 • Dec 05+ 1 more updateIDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 21.999999 million.IDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 21.999999 million. Security Name: Shares Security Type: Common Stock Securities Offered: 5,690,970 Price\Range: NOK 3 Security Name: Shares Security Type: Common Stock Securities Offered: 1,642,363 Price\Range: NOK 3 Transaction Features: Rule 144A; Subsequent Direct ListingReported Earnings • Nov 15Third quarter 2025 earnings released: US$0.02 loss per share (vs US$0.43 profit in 3Q 2024)Third quarter 2025 results: US$0.02 loss per share (down from US$0.43 profit in 3Q 2024). Net loss: US$992.0k (down 173% from profit in 3Q 2024).공시 • Sep 27Reserve Bank of India Approves Biometric Payment Authentication TechnologyReserve Bank of India (RBI) has approved biometric authentication technology for digital payments, including IDEX's fingerprint payment solutions, through new authentication mechanisms for digital payment transactions directions effective April 2026. The RBI mandate specifically endorses fingerprint biometric authentication as an approved method for India's digital payment ecosystem, moving beyond traditional SMS-based one-time passwords. This regulatory approval validates IDEX's strategic positioning in the Indian market. The IDEX Pay solution performs biometric authentication directly on the payment card without requiring infrastructure changes to existing merchant terminals. The technology ensures biometric data remains encrypted and stored exclusively on the card, addressing the RBI's enhanced security requirements while maintaining user privacy.공시 • Sep 12IDEX Biometrics ASA Launches New Product Portfolio for Payment and Access SolutionsIDEX Biometrics ASA announced the launch of its new product portfolio for payment and access solutions, accompanied by a redesigned website showcasing the company's advanced biometric authentication offerings. This launch marks a key milestone in the company's strategic transformation and delivery on previously communicated commitments.Reported Earnings • Aug 27Second quarter 2025 earnings released: US$0.07 loss per share (vs US$2.29 loss in 2Q 2024)Second quarter 2025 results: US$0.07 loss per share (improved from US$2.29 loss in 2Q 2024). Net loss: US$2.07m (loss narrowed 69% from 2Q 2024).공시 • Jul 22IDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 30 million.IDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 30 million. Security Name: Shares Security Type: Common Stock Securities Offered: 4,731,594 Price\Range: NOK 3.3 Discount Per Security: NOK 0.165 Security Name: Shares Security Type: Common Stock Securities Offered: 4,359,315 Price\Range: NOK 3.3 Discount Per Security: NOK 0.165 Transaction Features: Subsequent Direct Listing공시 • Jun 30IDEX Biometrics ASA Announces Chief Financial Officer Changes, Effective 30 June 2025IDEX Biometrics ASA announced that Kristian Flaten, Chief Financial Officer (CFO), has handed in his resignation as CFO to pursue other opportunities. The resignation is effective on 30 June 2025. Anders Storbråten, existing Chief Executive Officer, will also assume the role as Chief Financial Officer, as of the effective date of Kristian's resignation. Kristian will be available to support the Company in a transition period to secure a smooth handover of the CFO functions to Anders.공시 • Jun 07IDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 6 million.IDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 6 million. Security Name: Shares Security Type: Common Stock Securities Offered: 600,000,000 Price\Range: NOK 0.01 Transaction Features: Rights Offering공시 • May 21IDEX Biometrics ASA Approves Board and Committee ChangesIDEX Biometrics ASA initiated a restructuring of its organization in 2024 to align with business opportunities and reduce costs. The company is consolidating development and business operations primarily in the UK and the EU/EEA. During 2025, the restructuring continued with further cost reductions and changes to the commercial strategy, with new management in place. The Nomination Committee of IDEX Biometrics ASA proposes that Morten Opstad, Annika Olsson, and Adriana Saitta, all current board members and European residents and nationals, form the new board of directors, with Morten Opstad serving as the Chair. The proposal is that they continue for a new term of two years. The Nomination Committee proposes that Mr. Morten Opstad is elected for a new two-year term in the capacity as Chair, and Ms. Annika Olsson and Ms. Adriana Saitta are also elected for a new two-year term as board members. The Nomination Committee's chair, Mr. Robert N. Keith, and member Mr. Harald Voigt were elected for a 2-year term at the 2023 AGM and are now standing for election. Mr. Robert N. Keith is willing to continue to serve for a new two-year period. Mr. Harald Voigt is willing to continue to serve for a new one-year term. Member of the Nomination Committee, Mr. Håvard Nilsson, was elected for a two-year term at the annual general meeting in 2024. The Nomination Committee emphasizes that the composition of the Nomination Committee should be subject to review each year, regardless of the term of election. The Nomination Committee proposes that Mr. Håvard Nilsson will continue for the second year of his term at the Nomination Committee. Mr. Robert N. Keith, chair of the Nomination Committee, is elected as chair of the Nomination Committee for a new period of two years. Mr. Harald Voigt is elected as a member of the Nomination Committee for a one-year term.공시 • May 08IDEX Biometrics ASA to Report Q3, 2025 Results on Nov 13, 2025IDEX Biometrics ASA announced that they will report Q3, 2025 results on Nov 13, 2025공시 • Mar 11+ 1 more updateIDEX Biometrics ASA has filed a Follow-on Equity Offering in the amount of NOK 6 million.IDEX Biometrics ASA has filed a Follow-on Equity Offering in the amount of NOK 6 million. Security Name: Shares Security Type: Common Stock Securities Offered: 600,000,000 Price\Range: NOK 0.01 Transaction Features: Rights Offering공시 • Jan 02+ 1 more updateIDEX Biometrics ASA, Annual General Meeting, May 21, 2025IDEX Biometrics ASA, Annual General Meeting, May 21, 2025.공시 • Jan 01+ 3 more updatesIDEX Biometrics ASA to Report Q4, 2025 Results on Feb 26, 2026IDEX Biometrics ASA announced that they will report Q4, 2025 results on Feb 26, 2026공시 • Oct 29IDEX Biometrics ASA Announces Chief Financial Officer ChangesIDEX Biometricshas appointed Kristian Flaten as Chief Financial Officer, effective November 1, 2024. Kristian Flaten brings over 25 years of financial leadership and experience with international business and financing, including from Asian growth markets, a strong focus for IDEX Biometrics. He has a proven track record in corporate finance, debt financing and business development in growth companies. Kristian has a background as CFO with Quantafuel ASA, recycling plastic waste, and as VP Corporate Finance with BW Offshore, oilfield services. Additionally, he has experience from the financial sector with Export Finance Norway and Handelsbanken. Kristian holds a Master of Science from NHH (Norwegian School of Economics), with majors in Finance and Strategy. He will be based at IDEX Biometrics headquarters in Oslo. Kristian Flaten is succeeding John Kurtzweil, who will continue to support the company in an advisory role.공시 • Oct 23IDEX Biometrics ASA to Report Q3, 2024 Results on Oct 29, 2024IDEX Biometrics ASA announced that they will report Q3, 2024 results on Oct 29, 2024공시 • Aug 28IDEX Biometrics ASA Introduces Biometric Payment Cards in IndiaIDEX Biometrics is bringing biometric authentication onto payment cards for the Indian market, together with a worldwide leader in payment services. India boasts more than 1 billion payment cards in circulation and has been a frontrunner in biometrics for many years. Live user experience and technology testing for the IDEX Pay biometric payment cards has been conducted with Indian payment service partner, giving excellent results, and proving that biometric payment cards can be deployed in a seamless and secure manner throughout India. Newly published research indicates that more than 90% of affluent consumers in India want biometric payment cards. The Reserve Bank of India (RBI) is driving out secure digital payments and is in consultation with Indian banks to mandate alternative multi-factor authentication methods for digital payment transactions. This includes biometric authentication and specifically fingerprints. The payment landscape in India is set to change. With an opportunity to grow contactless payments from current low adoption levels of 16%, the biometric card represents a new secure and convenient payment solution for India. The biometric authentication is performed directly on the payment card, no change to existing payment terminals and infrastructure is needed. Equally important, the IDEX Pay technology ensures cardholder's biometric data never leaves the card, confirming highest level of security and privacy for the consumer.공시 • Aug 22IDEX Biometrics ASA Announces Chief Executive Officer ChangesIDEX Biometrics ASA has appointed Catharina Eklof as the new Chief Executive Officer, effective as of 19 August 2024. Catharina Eklof has for the last three years served as Chief Commercial Officer for IDEX Biometrics, and has been instrumental in the transformation from a component provider to a full biometric solution company. Catharina brings global experience in business transformation and has been driving profitable growth initiatives and led commercialization of new technology solutions across industry leading global companies as Mastercard and Securitas. The company thank Vince Graziani for his contributions to the company through challenging times. Vince will continue to support the company in an advisory role.공시 • Aug 15+ 1 more updateIDEX Biometrics ASA has withdrawn its Follow-on Equity Offering in the amount of NOK 13.2 million.IDEX Biometrics ASA has withdrawn its Follow-on Equity Offering in the amount of NOK 13.2 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 8,000,000 Price\Range: NOK 1.65 Transaction Features: Rights Offering공시 • May 18IDEX Biometrics ASA Appoints Morten Opstad as ChairIDEX Biometrics ASA at its annual general meeting on 16 May 2024 elected Morten Opstad as Chair.공시 • May 17+ 1 more updateIDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 55 million.IDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 55 million. Security Name: Shares Security Type: Common Stock Securities Offered: 28,012,655 Price\Range: NOK 1.65 Security Name: Shares Security Type: Common Stock Securities Offered: 5,320,678 Price\Range: NOK 1.65 Transaction Features: Subsequent Direct Listing공시 • Dec 19+ 5 more updatesIDEX Biometrics ASA, Annual General Meeting, May 16, 2024IDEX Biometrics ASA, Annual General Meeting, May 16, 2024.공시 • Nov 17+ 1 more updateIDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 35 million.IDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 35 million. Security Name: Shares Security Type: Common Stock Securities Offered: 78,651,685 Price\Range: NOK 0.445 Transaction Features: Subsequent Direct Listing공시 • Nov 08IDEX Biometrics ASA announced that it expects to receive NOK 100 million in fundingIDEX Biometrics ASA announced that it has entered into a non-binding term sheet to issue senior convertible bond for the gross proceeds of NOK 100 million on November 7, 2023. The bonds will have a coupon rate of 6% per annum. The convertible bond will be issued at a price of 92% of the principal amount, and will be amortized over 3,5 years through instalment every 2 months over the period. The instalment periods may be altered during the amortizing period. Conversion price will be at a premium to the stock price at closing of the final agreements and any repayments by issuance of shares will be at a discount to market price at each instalment. The transaction subject to approval of the formal agreements and shareholder approval.공시 • Sep 25IDEX Biometrics ASA Announces Chief Financial Officer ChangesIDEX Biometrics ASA has appointed John T. Kurtzweil as Chief Financial Officer effective September 25, 2023. Mr. Kurtzweil is a highly accomplished financial executive. He joins IDEX Biometrics after having served as CFO at Metabolon, where he was pivotal in revitalizing the company. Prior to Metabolon, he has served as CFO for CREE, Cirrus Logic and ON Semiconductor where he had key roles in finance operations at large, and leading strategic planning as well as mergers and acquisitions, growing shareholder value. Mr. Kurtzweil succeeds Eileen Wynne who has been Interim CFO in IDEX Biometrics since August 2022. Ms. Wynne will continue as a consultant during a transition period.공시 • Sep 01IDEX Biometrics Payment Card Solution Fully Certified by MastercardIDEX Biometrics has successfully completed the full Mastercard certification and received Conformity Compliance Statement (CCS) for its IDEX Biometrics Payment Card solution. The complete and certified biometric card solution includes the IDEX biometric sensor, a Linxens EMV module including Infineon's SLC38B secure element, card inlay with antenna, and the IDEX card operating system with payment applets. Biometric payment cards built on the IDEX Biometrics payment card solution will provide seamless payment experiences for consumers around the world. The IDEX Biometrics payment Card solution has successfully completed Mastercard's Compliance Assessment and Security Testing (CAST). This is the final Mastercard certification step and follows the previously announced FTAS certification of the sensor performance. Smartcard manufacturers can now fully leverage this certification for their Letters of Approval (LoA) without having to complete compliance tests on their own, significantly reducing development cost and time to market. More than 15 global and regional card manufacturers and resellers have already selected the IDEX Biometrics certified payment card solution, as they respond to the increasing demand from banks and fintechs for biometric payment cards. Mastercard Compliance Assessment and Security Testing (Cast) and Interface and Application Testing (IAT). Testing performed by independent certified test labs accredited by EMVCo and qualified by Mastercard2 EMV stands for Europay, Mastercard and Visa.공시 • Jul 23IDEX Biometrics Announces Intention to Voluntary Delist of American Depositary Shares from the Nasdaq Capital MarketIDEX Biometrics ASA announced it has given formal notice to the Nasdaq Stock Market of the Company’s intention to voluntary delist American Depositary Shares (“ADSs’) representing its ordinary shares, which is anticipated to be effective prior to the opening of trading on August 10, 2023. Each ADS represents 75 ordinary shares of the Company. Ordinary shares of IDEX Biometrics have been listed on the Oslo Bors since May 11, 2015, under the ticker IDEX.OL. The ordinary shares trade in Norwegian krone. The Company subsequently listed the ADSs on The Nasdaq Capital Market in March 2021 under the ticker IDBA. The ADSs trade in U.S. dollars. The ADS delisting will have no impact on the Company’s accounting standards, and IDEX intends to continue its disclosures in compliance with applicable Norwegian financial market regulations. IDEX intends to file a Form 25 and, thereafter, a Form 15F with the Securities and Exchange Commission (“SEC”) within the coming weeks to initiate the removal of the ADS listing and deregistration of the ADSs and underlying ordinary shares under the Securities Exchange Act of 1934, as amended (“Exchange Act”), and expects the ADS delisting to become effective on or around August 10, 2023, at which time the Company’s ADSs will no longer trade on The Nasdaq Capital Market and the IDEX reporting obligations with the SEC will be suspended. The Company expects that the deregistration of the ADSs and the underlying ordinary shares under the Exchange Act will become effective on or around October 29, 2023.공시 • May 26IDEX Biometrics ASA announced that it expects to receive NOK 150 million in fundingIDEX Biometrics ASA announced a private placement to raise gross proceeds of NOK 150 million in an equity round of funding on May 24, 2023. The transaction will include participation from Norwegian and international investors. The private placement will be divided into two tranches. Tranche 1 will consist of 116,897,492 offer shares. Tranche 2 will consist of up to the number of offer shares that, together with the tranche 1 offer shares, is necessary to raise gross proceeds of NOK 150 million. The allocations of offer shares to investors are expected to be split between Tranche 1 and Tranche 2 on a pro rata basis. The investors are subject to applicable exemptions from relevant prospectus, filing or other registration requirements. The minimum application and allocation amount in the private placement will be the NOK equivalent of €100,000. The company will announce the final number of offer shares placed and the final offer price in a stock exchange announcement expected to be published before the opening of trading on the Oslo Stock Exchange tomorrow, 25 May 2023. The completion of Tranche 1 is subject to approval by the board. The completion of tranche 2 will be subject to approval by an extraordinary general meeting of the company expected to be held on or about 16 June 2023. The settlement of the Tranche 1 offer shares is expected to take place on a delivery versus payment basis on or about 30 May 2023. Settlement of the Tranche 2 offer shares is expected to take place on a delivery versus payment basis on or about 20 June 2023.공시 • May 24IDEX Biometrics ASA Approves the Election of Adriana Saitta as Board MemberIDEX Biometrics ASA at its annual general meeting held on 23 May 2023 approved the election of Adriana Saitta as board member.공시 • May 12IDEX Biometrics Launches a Complete Biometric Payment Card Solution Leveraging Products and Technologies from STMicroelectronicsIDEX Biometrics has developed an advanced solution for biometric smart cards, leveraging products and technologies from STMicroelectronics. The solution combines the biometric system from IDEX Biometrics with the latest Secure Element from ST and is fully integrated with ST's STPay-Topaz-Bio Operating System and payment applets. This high-performance solution includes the ST31N600 secure microcontroller with biometric features, packaged in a single-chip EMV module, and includes a cost- effective enrollment solution. Bringing these innovations to market enables cost efficiencies for manufacturers and significantly improves the user experience. The solution is now completely tested and validated, demonstrating market-leading biometric performance and transaction latency. This new IDEX Biometrics smart card solution is targeted for deployment with banks and issuers in the first half of 2024.Reported Earnings • May 02Full year 2022 earnings: EPS and revenues exceed analyst expectationsFull year 2022 results: US$0.032 loss per share. Revenue: US$4.09m (up 44% from FY 2021). Net loss: US$32.7m (flat on FY 2021). Revenue exceeded analyst estimates by 5.1%. Earnings per share (EPS) also surpassed analyst estimates by 3.7%. Revenue is forecast to grow 105% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Electronic industry in Norway.Reported Earnings • Feb 22Full year 2022 earnings: EPS and revenues exceed analyst expectationsFull year 2022 results: US$0.03 loss per share. Revenue: US$4.09m (up 44% from FY 2021). Net loss: US$32.7m (flat on FY 2021). Revenue exceeded analyst estimates by 5.1%. Earnings per share (EPS) also surpassed analyst estimates by 3.7%.공시 • Dec 23+ 3 more updatesIDEX Biometrics ASA to Report Q3, 2023 Results on Nov 09, 2023IDEX Biometrics ASA announced that they will report Q3, 2023 results on Nov 09, 2023Reported Earnings • Nov 16Third quarter 2022 earnings released: US$0.009 loss per share (vs US$0.008 loss in 3Q 2021)Third quarter 2022 results: US$0.009 loss per share (further deteriorated from US$0.008 loss in 3Q 2021). Revenue: US$928.0k (up 27% from 3Q 2021). Net loss: US$9.02m (loss widened 21% from 3Q 2021). Revenue is forecast to grow 200% p.a. on average during the next 2 years, compared to a 34% growth forecast for the Electronic industry in Norway. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.Reported Earnings • Nov 12Third quarter 2022 earnings released: US$0.01 loss per share (vs US$0.008 loss in 3Q 2021)Third quarter 2022 results: US$0.01 loss per share (further deteriorated from US$0.008 loss in 3Q 2021). Revenue: US$928.0k (up 27% from 3Q 2021). Net loss: US$9.02m (loss widened 21% from 3Q 2021). Revenue is forecast to grow 193% p.a. on average during the next 2 years, compared to a 31% growth forecast for the Electronic industry in Norway. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.Breakeven Date Change • Sep 28Forecast to breakeven in 2024The 2 analysts covering IDEX Biometrics expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 65% per year to 2023. The company is expected to make a profit of US$200.0k in 2024. Average annual earnings growth of 84% is required to achieve expected profit on schedule.분석 기사 • Sep 11Here's Why IDEX Biometrics (OB:IDEX) Must Use Its Cash WiselyThere's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...Reported Earnings • Aug 12Second quarter 2022 earnings released: US$0.01 loss per share (vs US$0.008 loss in 2Q 2021)Second quarter 2022 results: US$0.01 loss per share (down from US$0.008 loss in 2Q 2021). Revenue: US$1.11m (up 59% from 2Q 2021). Net loss: US$9.24m (loss widened 28% from 2Q 2021). Over the next year, revenue is forecast to grow 573%, compared to a 119% growth forecast for the industry in Norway. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.Reported Earnings • May 13First quarter 2022 earnings: EPS and revenues miss analyst expectationsFirst quarter 2022 results: US$0.01 loss per share (down from US$0.009 loss in 1Q 2021). Revenue: US$989.0k (up 59% from 1Q 2021). Net loss: US$8.12m (loss widened 7.9% from 1Q 2021). Revenue missed analyst estimates by 36%. Earnings per share (EPS) also missed analyst estimates by 38%. Over the next year, revenue is forecast to grow 474%, compared to a 169% growth forecast for the industry in Norway. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has fallen by 29% per year, which means it is significantly lagging earnings.Reported Earnings • Feb 28Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: US$0.035 loss per share (vs US$0.035 loss in FY 2020). Net loss: US$32.6m (loss widened 22% from FY 2020). Revenue exceeded analyst estimates by 2.4%. Over the next year, revenue is forecast to grow 483%, compared to a 216% growth forecast for the industry in Norway. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has fallen by 21% per year, which means it is significantly lagging earnings.Breakeven Date Change • Jan 01Forecast to breakeven in 2024The 2 analysts covering IDEX Biometrics expect the company to break even for the first time. New consensus forecast suggests the company will make a profit of US$200.0k in 2024. Average annual earnings growth of 55% is required to achieve expected profit on schedule.Reported Earnings • Nov 06Third quarter 2021 earnings released: US$0.01 loss per share (vs US$0.009 loss in 3Q 2020)The company reported a solid third quarter result with improved revenues and control over costs, although losses increased. Third quarter 2021 results: Revenue: US$732.0k (up 195% from 3Q 2020). Net loss: US$7.47m (loss widened 10.0% from 3Q 2020). Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings.분석 기사 • Oct 23We Think IDEX Biometrics (OB:IDEX) Needs To Drive Business Growth CarefullyJust because a business does not make any money, does not mean that the stock will go down. For example, biotech and...Reported Earnings • Aug 13Second quarter 2021 earnings released: US$0.01 loss per share (vs US$0.009 loss in 2Q 2020)The company reported a solid second quarter result with improved revenues and control over costs, although losses increased. Second quarter 2021 results: Revenue: US$697.0k (up 368% from 2Q 2020). Net loss: US$7.24m (loss widened 13% from 2Q 2020). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings.분석 기사 • May 14We Think IDEX Biometrics (OB:IDEX) Needs To Drive Business Growth CarefullyWe can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...Reported Earnings • May 13First quarter 2021 earnings released: US$0.01 loss per share (vs US$0.009 loss in 1Q 2020)First quarter 2021 results: Net loss: US$7.53m (loss widened 19% from 1Q 2020). Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 19% per year, which means it is significantly lagging earnings.Executive Departure • May 04Advisor has left the companyOn the 1st of May, Derek D'Antilio's tenure as Advisor ended after less than a year in the role. As of December 2020, Derek personally held 681.93k shares (kr2.0m worth at the time). Derek is the only executive to leave the company over the last 12 months.Reported Earnings • Apr 25Full year 2020 earnings released: US$0.035 loss per share (vs US$0.054 loss in FY 2019)Full year 2020 results: Net loss: US$26.8m (loss narrowed 18% from FY 2019). Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings.분석 기사 • Mar 03Chief Executive Officer Vincent Graziani Just Bought 19% More Shares In IDEX Biometrics ASA (OB:IDEX)Those following along with IDEX Biometrics ASA ( OB:IDEX ) will no doubt be intrigued by the recent purchase of shares...Recent Insider Transactions • Mar 03Chief Executive Officer recently bought kr37m worth of stockOn the 1st of March, Vincent Graziani bought around 150k shares on-market at roughly kr246 per share. This was the largest purchase by an insider in the last 3 months. Vincent has been a buyer over the last 12 months, purchasing a net total of kr38m worth in shares.분석 기사 • Feb 27Did The Underlying Business Drive IDEX Biometrics' (OB:IDEX) Lovely 324% Share Price Gain?For many, the main point of investing in the stock market is to achieve spectacular returns. When an investor finds a...Reported Earnings • Feb 26Full year 2020 earnings released: US$0.03 loss per share (vs US$0.055 loss in FY 2019)Full year 2020 results: Net loss: US$26.8m (loss narrowed 18% from FY 2019). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings.Analyst Estimate Surprise Post Earnings • Feb 26Revenue and earnings miss expectationsRevenue missed analyst estimates by 3.8%. Earnings per share (EPS) also missed analyst estimates by 16%. Over the next year, revenue is forecast to grow 357%, compared to a 235% growth forecast for the Electronic industry in Norway.Is New 90 Day High Low • Feb 22New 90-day high: kr3.33The company is up 70% from its price of kr1.95 on 24 November 2020. The Norwegian market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 27% over the same period.Is New 90 Day High Low • Dec 28New 90-day high: kr3.10The company is up 49% from its price of kr2.08 on 29 September 2020. The Norwegian market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 7.0% over the same period.매출 및 비용 세부 내역IDEX Biometrics가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이OB:IDEX 매출, 비용 및 순이익 (NOK Millions)날짜매출순이익일반관리비연구개발비31 Mar 263-92281131 Dec 253-101271430 Sep 252-109331330 Jun 253-86472331 Mar 256-139692531 Dec 2410-1641002830 Sep 2414-1651042530 Jun 2423-2571242031 Mar 2435-2691412231 Dec 2342-2711452430 Sep 2351-2991753130 Jun 2350-3221913331 Mar 2345-3331953331 Dec 2240-3201883230 Sep 2242-4002303930 Jun 2236-3462083131 Mar 2228-2921852731 Dec 2125-2871862430 Sep 2123-2581751830 Jun 2119-2491662031 Mar 2114-2391552131 Dec 209-2291521630 Sep 205-2701783230 Jun 205-2861913331 Mar 204-3212193431 Dec 194-2851913830 Sep 194-2721713830 Jun 193-2561583831 Mar 193-2581584531 Dec 184-2611714930 Sep 186-2481414530 Jun 188-2511425231 Mar 1813-2521425231 Dec 1717-2551405630 Sep 1727-2351345930 Jun 1732-2301276531 Mar 1742-2091057131 Dec 1639-203908130 Sep 1626-2349010630 Jun 1618-2297310731 Mar 164-2347411231 Dec 150-2297610330 Sep 151-1967884양질의 수익: IDEX 은(는) 현재 수익성이 없습니다.이익 마진 증가: IDEX는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: IDEX는 수익성이 없지만 지난 5년 동안 연평균 18.6%의 속도로 손실을 줄였습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 IDEX의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: IDEX은 수익성이 없어 지난 해 수익 성장률을 Electronic 업계(7.8%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: IDEX의 부채가 자산을 초과하여 자본 수익률을 계산하기 어렵습니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YTech 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/07/09 15:38종가2026/07/09 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스IDEX Biometrics ASA는 5명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Hans Rettedal ChristiansenCarnegie Investment Bank ABJonas LisauskasNorne Securities ASAuguste RichardNorthland Capital Markets2명의 분석가 더 보기
Reported Earnings • Mar 05Full year 2025 earnings released: US$0.26 loss per share (vs US$3.49 loss in FY 2024)Full year 2025 results: US$0.26 loss per share (improved from US$3.49 loss in FY 2024). Net loss: US$10.0m (loss narrowed 31% from FY 2024).
공시 • Dec 31+ 3 more updatesIDEX Biometrics ASA to Report First Half, 2026 Results on Aug 20, 2026IDEX Biometrics ASA announced that they will report first half, 2026 results on Aug 20, 2026
Reported Earnings • Nov 15Third quarter 2025 earnings released: US$0.02 loss per share (vs US$0.43 profit in 3Q 2024)Third quarter 2025 results: US$0.02 loss per share (down from US$0.43 profit in 3Q 2024). Net loss: US$992.0k (down 173% from profit in 3Q 2024).
Reported Earnings • Aug 27Second quarter 2025 earnings released: US$0.07 loss per share (vs US$2.29 loss in 2Q 2024)Second quarter 2025 results: US$0.07 loss per share (improved from US$2.29 loss in 2Q 2024). Net loss: US$2.07m (loss narrowed 69% from 2Q 2024).
공시 • May 08IDEX Biometrics ASA to Report Q3, 2025 Results on Nov 13, 2025IDEX Biometrics ASA announced that they will report Q3, 2025 results on Nov 13, 2025
공시 • Jan 01+ 3 more updatesIDEX Biometrics ASA to Report Q4, 2025 Results on Feb 26, 2026IDEX Biometrics ASA announced that they will report Q4, 2025 results on Feb 26, 2026
Board Change • Jun 10High number of new directorsExecutive Chairman of the Board Anders Storbraten was the last director to join the board, commencing their role in 2026.
공시 • Jun 05IDEX Biometrics ASA has filed a Follow-on Equity Offering in the amount of NOK 20.625 million.IDEX Biometrics ASA has filed a Follow-on Equity Offering in the amount of NOK 20.625 million. Security Name: Shares Security Type: Common Stock Securities Offered: 2,500,000 Price\Range: NOK 8.25 Transaction Features: Subsequent Direct Listing
공시 • May 30IDEX Biometrics ASA has withdrawn its Follow-on Equity Offering in the amount of NOK 19.999997 million.IDEX Biometrics ASA has withdrawn its Follow-on Equity Offering in the amount of NOK 19.999997 million. Security Name: Shares Security Type: Common Stock Securities Offered: 2,424,242 Price\Range: NOK 8.25 Transaction Features: Rights Offering
공시 • Apr 29IDEX Biometrics ASA has filed a Follow-on Equity Offering in the amount of NOK 19.999997 million.IDEX Biometrics ASA has filed a Follow-on Equity Offering in the amount of NOK 19.999997 million. Security Name: Shares Security Type: Common Stock Securities Offered: 2,424,242 Price\Range: NOK 8.25 Transaction Features: Rights Offering
공시 • Mar 06IDEX Biometrics ASA announced that it expects to receive NOK 90.000001 million in fundingIDEX Biometrics ASA announced a private placement to issue NOK 90,000,000 to ID centric in two tranches on March 5, 2026.The first tranche with 3,824,233 new shares at a price of NOK 5.83 per share for gross proceeds of NOK 2,2295,278.39 and it is getting closed on the same day. The second tranche with 11,613,159.795883 at a price of NOK 5.83 per share for gross proceeds of NOK 67,704,721.609998. The first tranche has been approved by the board of directors and an extraordinary general meeting will be held on or about March 27, 2026 to seek the necessary approval for the second tranche.
Reported Earnings • Mar 05Full year 2025 earnings released: US$0.26 loss per share (vs US$3.49 loss in FY 2024)Full year 2025 results: US$0.26 loss per share (improved from US$3.49 loss in FY 2024). Net loss: US$10.0m (loss narrowed 31% from FY 2024).
공시 • Jan 02IDEX Biometrics ASA, Annual General Meeting, May 21, 2026IDEX Biometrics ASA, Annual General Meeting, May 21, 2026.
공시 • Dec 31+ 3 more updatesIDEX Biometrics ASA to Report First Half, 2026 Results on Aug 20, 2026IDEX Biometrics ASA announced that they will report first half, 2026 results on Aug 20, 2026
New Risk • Dec 23New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Norwegian stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Shareholders have been substantially diluted in the past year (over 5x increase in shares outstanding). Revenue is less than US$1m (US$209k revenue). Minor Risk Market cap is less than US$100m (kr362.3m market cap, or US$36.0m).
공시 • Dec 05+ 1 more updateIDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 21.999999 million.IDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 21.999999 million. Security Name: Shares Security Type: Common Stock Securities Offered: 5,690,970 Price\Range: NOK 3 Security Name: Shares Security Type: Common Stock Securities Offered: 1,642,363 Price\Range: NOK 3 Transaction Features: Rule 144A; Subsequent Direct Listing
Reported Earnings • Nov 15Third quarter 2025 earnings released: US$0.02 loss per share (vs US$0.43 profit in 3Q 2024)Third quarter 2025 results: US$0.02 loss per share (down from US$0.43 profit in 3Q 2024). Net loss: US$992.0k (down 173% from profit in 3Q 2024).
공시 • Sep 27Reserve Bank of India Approves Biometric Payment Authentication TechnologyReserve Bank of India (RBI) has approved biometric authentication technology for digital payments, including IDEX's fingerprint payment solutions, through new authentication mechanisms for digital payment transactions directions effective April 2026. The RBI mandate specifically endorses fingerprint biometric authentication as an approved method for India's digital payment ecosystem, moving beyond traditional SMS-based one-time passwords. This regulatory approval validates IDEX's strategic positioning in the Indian market. The IDEX Pay solution performs biometric authentication directly on the payment card without requiring infrastructure changes to existing merchant terminals. The technology ensures biometric data remains encrypted and stored exclusively on the card, addressing the RBI's enhanced security requirements while maintaining user privacy.
공시 • Sep 12IDEX Biometrics ASA Launches New Product Portfolio for Payment and Access SolutionsIDEX Biometrics ASA announced the launch of its new product portfolio for payment and access solutions, accompanied by a redesigned website showcasing the company's advanced biometric authentication offerings. This launch marks a key milestone in the company's strategic transformation and delivery on previously communicated commitments.
Reported Earnings • Aug 27Second quarter 2025 earnings released: US$0.07 loss per share (vs US$2.29 loss in 2Q 2024)Second quarter 2025 results: US$0.07 loss per share (improved from US$2.29 loss in 2Q 2024). Net loss: US$2.07m (loss narrowed 69% from 2Q 2024).
공시 • Jul 22IDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 30 million.IDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 30 million. Security Name: Shares Security Type: Common Stock Securities Offered: 4,731,594 Price\Range: NOK 3.3 Discount Per Security: NOK 0.165 Security Name: Shares Security Type: Common Stock Securities Offered: 4,359,315 Price\Range: NOK 3.3 Discount Per Security: NOK 0.165 Transaction Features: Subsequent Direct Listing
공시 • Jun 30IDEX Biometrics ASA Announces Chief Financial Officer Changes, Effective 30 June 2025IDEX Biometrics ASA announced that Kristian Flaten, Chief Financial Officer (CFO), has handed in his resignation as CFO to pursue other opportunities. The resignation is effective on 30 June 2025. Anders Storbråten, existing Chief Executive Officer, will also assume the role as Chief Financial Officer, as of the effective date of Kristian's resignation. Kristian will be available to support the Company in a transition period to secure a smooth handover of the CFO functions to Anders.
공시 • Jun 07IDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 6 million.IDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 6 million. Security Name: Shares Security Type: Common Stock Securities Offered: 600,000,000 Price\Range: NOK 0.01 Transaction Features: Rights Offering
공시 • May 21IDEX Biometrics ASA Approves Board and Committee ChangesIDEX Biometrics ASA initiated a restructuring of its organization in 2024 to align with business opportunities and reduce costs. The company is consolidating development and business operations primarily in the UK and the EU/EEA. During 2025, the restructuring continued with further cost reductions and changes to the commercial strategy, with new management in place. The Nomination Committee of IDEX Biometrics ASA proposes that Morten Opstad, Annika Olsson, and Adriana Saitta, all current board members and European residents and nationals, form the new board of directors, with Morten Opstad serving as the Chair. The proposal is that they continue for a new term of two years. The Nomination Committee proposes that Mr. Morten Opstad is elected for a new two-year term in the capacity as Chair, and Ms. Annika Olsson and Ms. Adriana Saitta are also elected for a new two-year term as board members. The Nomination Committee's chair, Mr. Robert N. Keith, and member Mr. Harald Voigt were elected for a 2-year term at the 2023 AGM and are now standing for election. Mr. Robert N. Keith is willing to continue to serve for a new two-year period. Mr. Harald Voigt is willing to continue to serve for a new one-year term. Member of the Nomination Committee, Mr. Håvard Nilsson, was elected for a two-year term at the annual general meeting in 2024. The Nomination Committee emphasizes that the composition of the Nomination Committee should be subject to review each year, regardless of the term of election. The Nomination Committee proposes that Mr. Håvard Nilsson will continue for the second year of his term at the Nomination Committee. Mr. Robert N. Keith, chair of the Nomination Committee, is elected as chair of the Nomination Committee for a new period of two years. Mr. Harald Voigt is elected as a member of the Nomination Committee for a one-year term.
공시 • May 08IDEX Biometrics ASA to Report Q3, 2025 Results on Nov 13, 2025IDEX Biometrics ASA announced that they will report Q3, 2025 results on Nov 13, 2025
공시 • Mar 11+ 1 more updateIDEX Biometrics ASA has filed a Follow-on Equity Offering in the amount of NOK 6 million.IDEX Biometrics ASA has filed a Follow-on Equity Offering in the amount of NOK 6 million. Security Name: Shares Security Type: Common Stock Securities Offered: 600,000,000 Price\Range: NOK 0.01 Transaction Features: Rights Offering
공시 • Jan 02+ 1 more updateIDEX Biometrics ASA, Annual General Meeting, May 21, 2025IDEX Biometrics ASA, Annual General Meeting, May 21, 2025.
공시 • Jan 01+ 3 more updatesIDEX Biometrics ASA to Report Q4, 2025 Results on Feb 26, 2026IDEX Biometrics ASA announced that they will report Q4, 2025 results on Feb 26, 2026
공시 • Oct 29IDEX Biometrics ASA Announces Chief Financial Officer ChangesIDEX Biometricshas appointed Kristian Flaten as Chief Financial Officer, effective November 1, 2024. Kristian Flaten brings over 25 years of financial leadership and experience with international business and financing, including from Asian growth markets, a strong focus for IDEX Biometrics. He has a proven track record in corporate finance, debt financing and business development in growth companies. Kristian has a background as CFO with Quantafuel ASA, recycling plastic waste, and as VP Corporate Finance with BW Offshore, oilfield services. Additionally, he has experience from the financial sector with Export Finance Norway and Handelsbanken. Kristian holds a Master of Science from NHH (Norwegian School of Economics), with majors in Finance and Strategy. He will be based at IDEX Biometrics headquarters in Oslo. Kristian Flaten is succeeding John Kurtzweil, who will continue to support the company in an advisory role.
공시 • Oct 23IDEX Biometrics ASA to Report Q3, 2024 Results on Oct 29, 2024IDEX Biometrics ASA announced that they will report Q3, 2024 results on Oct 29, 2024
공시 • Aug 28IDEX Biometrics ASA Introduces Biometric Payment Cards in IndiaIDEX Biometrics is bringing biometric authentication onto payment cards for the Indian market, together with a worldwide leader in payment services. India boasts more than 1 billion payment cards in circulation and has been a frontrunner in biometrics for many years. Live user experience and technology testing for the IDEX Pay biometric payment cards has been conducted with Indian payment service partner, giving excellent results, and proving that biometric payment cards can be deployed in a seamless and secure manner throughout India. Newly published research indicates that more than 90% of affluent consumers in India want biometric payment cards. The Reserve Bank of India (RBI) is driving out secure digital payments and is in consultation with Indian banks to mandate alternative multi-factor authentication methods for digital payment transactions. This includes biometric authentication and specifically fingerprints. The payment landscape in India is set to change. With an opportunity to grow contactless payments from current low adoption levels of 16%, the biometric card represents a new secure and convenient payment solution for India. The biometric authentication is performed directly on the payment card, no change to existing payment terminals and infrastructure is needed. Equally important, the IDEX Pay technology ensures cardholder's biometric data never leaves the card, confirming highest level of security and privacy for the consumer.
공시 • Aug 22IDEX Biometrics ASA Announces Chief Executive Officer ChangesIDEX Biometrics ASA has appointed Catharina Eklof as the new Chief Executive Officer, effective as of 19 August 2024. Catharina Eklof has for the last three years served as Chief Commercial Officer for IDEX Biometrics, and has been instrumental in the transformation from a component provider to a full biometric solution company. Catharina brings global experience in business transformation and has been driving profitable growth initiatives and led commercialization of new technology solutions across industry leading global companies as Mastercard and Securitas. The company thank Vince Graziani for his contributions to the company through challenging times. Vince will continue to support the company in an advisory role.
공시 • Aug 15+ 1 more updateIDEX Biometrics ASA has withdrawn its Follow-on Equity Offering in the amount of NOK 13.2 million.IDEX Biometrics ASA has withdrawn its Follow-on Equity Offering in the amount of NOK 13.2 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 8,000,000 Price\Range: NOK 1.65 Transaction Features: Rights Offering
공시 • May 18IDEX Biometrics ASA Appoints Morten Opstad as ChairIDEX Biometrics ASA at its annual general meeting on 16 May 2024 elected Morten Opstad as Chair.
공시 • May 17+ 1 more updateIDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 55 million.IDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 55 million. Security Name: Shares Security Type: Common Stock Securities Offered: 28,012,655 Price\Range: NOK 1.65 Security Name: Shares Security Type: Common Stock Securities Offered: 5,320,678 Price\Range: NOK 1.65 Transaction Features: Subsequent Direct Listing
공시 • Dec 19+ 5 more updatesIDEX Biometrics ASA, Annual General Meeting, May 16, 2024IDEX Biometrics ASA, Annual General Meeting, May 16, 2024.
공시 • Nov 17+ 1 more updateIDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 35 million.IDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 35 million. Security Name: Shares Security Type: Common Stock Securities Offered: 78,651,685 Price\Range: NOK 0.445 Transaction Features: Subsequent Direct Listing
공시 • Nov 08IDEX Biometrics ASA announced that it expects to receive NOK 100 million in fundingIDEX Biometrics ASA announced that it has entered into a non-binding term sheet to issue senior convertible bond for the gross proceeds of NOK 100 million on November 7, 2023. The bonds will have a coupon rate of 6% per annum. The convertible bond will be issued at a price of 92% of the principal amount, and will be amortized over 3,5 years through instalment every 2 months over the period. The instalment periods may be altered during the amortizing period. Conversion price will be at a premium to the stock price at closing of the final agreements and any repayments by issuance of shares will be at a discount to market price at each instalment. The transaction subject to approval of the formal agreements and shareholder approval.
공시 • Sep 25IDEX Biometrics ASA Announces Chief Financial Officer ChangesIDEX Biometrics ASA has appointed John T. Kurtzweil as Chief Financial Officer effective September 25, 2023. Mr. Kurtzweil is a highly accomplished financial executive. He joins IDEX Biometrics after having served as CFO at Metabolon, where he was pivotal in revitalizing the company. Prior to Metabolon, he has served as CFO for CREE, Cirrus Logic and ON Semiconductor where he had key roles in finance operations at large, and leading strategic planning as well as mergers and acquisitions, growing shareholder value. Mr. Kurtzweil succeeds Eileen Wynne who has been Interim CFO in IDEX Biometrics since August 2022. Ms. Wynne will continue as a consultant during a transition period.
공시 • Sep 01IDEX Biometrics Payment Card Solution Fully Certified by MastercardIDEX Biometrics has successfully completed the full Mastercard certification and received Conformity Compliance Statement (CCS) for its IDEX Biometrics Payment Card solution. The complete and certified biometric card solution includes the IDEX biometric sensor, a Linxens EMV module including Infineon's SLC38B secure element, card inlay with antenna, and the IDEX card operating system with payment applets. Biometric payment cards built on the IDEX Biometrics payment card solution will provide seamless payment experiences for consumers around the world. The IDEX Biometrics payment Card solution has successfully completed Mastercard's Compliance Assessment and Security Testing (CAST). This is the final Mastercard certification step and follows the previously announced FTAS certification of the sensor performance. Smartcard manufacturers can now fully leverage this certification for their Letters of Approval (LoA) without having to complete compliance tests on their own, significantly reducing development cost and time to market. More than 15 global and regional card manufacturers and resellers have already selected the IDEX Biometrics certified payment card solution, as they respond to the increasing demand from banks and fintechs for biometric payment cards. Mastercard Compliance Assessment and Security Testing (Cast) and Interface and Application Testing (IAT). Testing performed by independent certified test labs accredited by EMVCo and qualified by Mastercard2 EMV stands for Europay, Mastercard and Visa.
공시 • Jul 23IDEX Biometrics Announces Intention to Voluntary Delist of American Depositary Shares from the Nasdaq Capital MarketIDEX Biometrics ASA announced it has given formal notice to the Nasdaq Stock Market of the Company’s intention to voluntary delist American Depositary Shares (“ADSs’) representing its ordinary shares, which is anticipated to be effective prior to the opening of trading on August 10, 2023. Each ADS represents 75 ordinary shares of the Company. Ordinary shares of IDEX Biometrics have been listed on the Oslo Bors since May 11, 2015, under the ticker IDEX.OL. The ordinary shares trade in Norwegian krone. The Company subsequently listed the ADSs on The Nasdaq Capital Market in March 2021 under the ticker IDBA. The ADSs trade in U.S. dollars. The ADS delisting will have no impact on the Company’s accounting standards, and IDEX intends to continue its disclosures in compliance with applicable Norwegian financial market regulations. IDEX intends to file a Form 25 and, thereafter, a Form 15F with the Securities and Exchange Commission (“SEC”) within the coming weeks to initiate the removal of the ADS listing and deregistration of the ADSs and underlying ordinary shares under the Securities Exchange Act of 1934, as amended (“Exchange Act”), and expects the ADS delisting to become effective on or around August 10, 2023, at which time the Company’s ADSs will no longer trade on The Nasdaq Capital Market and the IDEX reporting obligations with the SEC will be suspended. The Company expects that the deregistration of the ADSs and the underlying ordinary shares under the Exchange Act will become effective on or around October 29, 2023.
공시 • May 26IDEX Biometrics ASA announced that it expects to receive NOK 150 million in fundingIDEX Biometrics ASA announced a private placement to raise gross proceeds of NOK 150 million in an equity round of funding on May 24, 2023. The transaction will include participation from Norwegian and international investors. The private placement will be divided into two tranches. Tranche 1 will consist of 116,897,492 offer shares. Tranche 2 will consist of up to the number of offer shares that, together with the tranche 1 offer shares, is necessary to raise gross proceeds of NOK 150 million. The allocations of offer shares to investors are expected to be split between Tranche 1 and Tranche 2 on a pro rata basis. The investors are subject to applicable exemptions from relevant prospectus, filing or other registration requirements. The minimum application and allocation amount in the private placement will be the NOK equivalent of €100,000. The company will announce the final number of offer shares placed and the final offer price in a stock exchange announcement expected to be published before the opening of trading on the Oslo Stock Exchange tomorrow, 25 May 2023. The completion of Tranche 1 is subject to approval by the board. The completion of tranche 2 will be subject to approval by an extraordinary general meeting of the company expected to be held on or about 16 June 2023. The settlement of the Tranche 1 offer shares is expected to take place on a delivery versus payment basis on or about 30 May 2023. Settlement of the Tranche 2 offer shares is expected to take place on a delivery versus payment basis on or about 20 June 2023.
공시 • May 24IDEX Biometrics ASA Approves the Election of Adriana Saitta as Board MemberIDEX Biometrics ASA at its annual general meeting held on 23 May 2023 approved the election of Adriana Saitta as board member.
공시 • May 12IDEX Biometrics Launches a Complete Biometric Payment Card Solution Leveraging Products and Technologies from STMicroelectronicsIDEX Biometrics has developed an advanced solution for biometric smart cards, leveraging products and technologies from STMicroelectronics. The solution combines the biometric system from IDEX Biometrics with the latest Secure Element from ST and is fully integrated with ST's STPay-Topaz-Bio Operating System and payment applets. This high-performance solution includes the ST31N600 secure microcontroller with biometric features, packaged in a single-chip EMV module, and includes a cost- effective enrollment solution. Bringing these innovations to market enables cost efficiencies for manufacturers and significantly improves the user experience. The solution is now completely tested and validated, demonstrating market-leading biometric performance and transaction latency. This new IDEX Biometrics smart card solution is targeted for deployment with banks and issuers in the first half of 2024.
Reported Earnings • May 02Full year 2022 earnings: EPS and revenues exceed analyst expectationsFull year 2022 results: US$0.032 loss per share. Revenue: US$4.09m (up 44% from FY 2021). Net loss: US$32.7m (flat on FY 2021). Revenue exceeded analyst estimates by 5.1%. Earnings per share (EPS) also surpassed analyst estimates by 3.7%. Revenue is forecast to grow 105% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Electronic industry in Norway.
Reported Earnings • Feb 22Full year 2022 earnings: EPS and revenues exceed analyst expectationsFull year 2022 results: US$0.03 loss per share. Revenue: US$4.09m (up 44% from FY 2021). Net loss: US$32.7m (flat on FY 2021). Revenue exceeded analyst estimates by 5.1%. Earnings per share (EPS) also surpassed analyst estimates by 3.7%.
공시 • Dec 23+ 3 more updatesIDEX Biometrics ASA to Report Q3, 2023 Results on Nov 09, 2023IDEX Biometrics ASA announced that they will report Q3, 2023 results on Nov 09, 2023
Reported Earnings • Nov 16Third quarter 2022 earnings released: US$0.009 loss per share (vs US$0.008 loss in 3Q 2021)Third quarter 2022 results: US$0.009 loss per share (further deteriorated from US$0.008 loss in 3Q 2021). Revenue: US$928.0k (up 27% from 3Q 2021). Net loss: US$9.02m (loss widened 21% from 3Q 2021). Revenue is forecast to grow 200% p.a. on average during the next 2 years, compared to a 34% growth forecast for the Electronic industry in Norway. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Nov 12Third quarter 2022 earnings released: US$0.01 loss per share (vs US$0.008 loss in 3Q 2021)Third quarter 2022 results: US$0.01 loss per share (further deteriorated from US$0.008 loss in 3Q 2021). Revenue: US$928.0k (up 27% from 3Q 2021). Net loss: US$9.02m (loss widened 21% from 3Q 2021). Revenue is forecast to grow 193% p.a. on average during the next 2 years, compared to a 31% growth forecast for the Electronic industry in Norway. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.
Breakeven Date Change • Sep 28Forecast to breakeven in 2024The 2 analysts covering IDEX Biometrics expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 65% per year to 2023. The company is expected to make a profit of US$200.0k in 2024. Average annual earnings growth of 84% is required to achieve expected profit on schedule.
분석 기사 • Sep 11Here's Why IDEX Biometrics (OB:IDEX) Must Use Its Cash WiselyThere's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
Reported Earnings • Aug 12Second quarter 2022 earnings released: US$0.01 loss per share (vs US$0.008 loss in 2Q 2021)Second quarter 2022 results: US$0.01 loss per share (down from US$0.008 loss in 2Q 2021). Revenue: US$1.11m (up 59% from 2Q 2021). Net loss: US$9.24m (loss widened 28% from 2Q 2021). Over the next year, revenue is forecast to grow 573%, compared to a 119% growth forecast for the industry in Norway. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.
Reported Earnings • May 13First quarter 2022 earnings: EPS and revenues miss analyst expectationsFirst quarter 2022 results: US$0.01 loss per share (down from US$0.009 loss in 1Q 2021). Revenue: US$989.0k (up 59% from 1Q 2021). Net loss: US$8.12m (loss widened 7.9% from 1Q 2021). Revenue missed analyst estimates by 36%. Earnings per share (EPS) also missed analyst estimates by 38%. Over the next year, revenue is forecast to grow 474%, compared to a 169% growth forecast for the industry in Norway. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has fallen by 29% per year, which means it is significantly lagging earnings.
Reported Earnings • Feb 28Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: US$0.035 loss per share (vs US$0.035 loss in FY 2020). Net loss: US$32.6m (loss widened 22% from FY 2020). Revenue exceeded analyst estimates by 2.4%. Over the next year, revenue is forecast to grow 483%, compared to a 216% growth forecast for the industry in Norway. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has fallen by 21% per year, which means it is significantly lagging earnings.
Breakeven Date Change • Jan 01Forecast to breakeven in 2024The 2 analysts covering IDEX Biometrics expect the company to break even for the first time. New consensus forecast suggests the company will make a profit of US$200.0k in 2024. Average annual earnings growth of 55% is required to achieve expected profit on schedule.
Reported Earnings • Nov 06Third quarter 2021 earnings released: US$0.01 loss per share (vs US$0.009 loss in 3Q 2020)The company reported a solid third quarter result with improved revenues and control over costs, although losses increased. Third quarter 2021 results: Revenue: US$732.0k (up 195% from 3Q 2020). Net loss: US$7.47m (loss widened 10.0% from 3Q 2020). Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings.
분석 기사 • Oct 23We Think IDEX Biometrics (OB:IDEX) Needs To Drive Business Growth CarefullyJust because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
Reported Earnings • Aug 13Second quarter 2021 earnings released: US$0.01 loss per share (vs US$0.009 loss in 2Q 2020)The company reported a solid second quarter result with improved revenues and control over costs, although losses increased. Second quarter 2021 results: Revenue: US$697.0k (up 368% from 2Q 2020). Net loss: US$7.24m (loss widened 13% from 2Q 2020). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings.
분석 기사 • May 14We Think IDEX Biometrics (OB:IDEX) Needs To Drive Business Growth CarefullyWe can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
Reported Earnings • May 13First quarter 2021 earnings released: US$0.01 loss per share (vs US$0.009 loss in 1Q 2020)First quarter 2021 results: Net loss: US$7.53m (loss widened 19% from 1Q 2020). Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 19% per year, which means it is significantly lagging earnings.
Executive Departure • May 04Advisor has left the companyOn the 1st of May, Derek D'Antilio's tenure as Advisor ended after less than a year in the role. As of December 2020, Derek personally held 681.93k shares (kr2.0m worth at the time). Derek is the only executive to leave the company over the last 12 months.
Reported Earnings • Apr 25Full year 2020 earnings released: US$0.035 loss per share (vs US$0.054 loss in FY 2019)Full year 2020 results: Net loss: US$26.8m (loss narrowed 18% from FY 2019). Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings.
분석 기사 • Mar 03Chief Executive Officer Vincent Graziani Just Bought 19% More Shares In IDEX Biometrics ASA (OB:IDEX)Those following along with IDEX Biometrics ASA ( OB:IDEX ) will no doubt be intrigued by the recent purchase of shares...
Recent Insider Transactions • Mar 03Chief Executive Officer recently bought kr37m worth of stockOn the 1st of March, Vincent Graziani bought around 150k shares on-market at roughly kr246 per share. This was the largest purchase by an insider in the last 3 months. Vincent has been a buyer over the last 12 months, purchasing a net total of kr38m worth in shares.
분석 기사 • Feb 27Did The Underlying Business Drive IDEX Biometrics' (OB:IDEX) Lovely 324% Share Price Gain?For many, the main point of investing in the stock market is to achieve spectacular returns. When an investor finds a...
Reported Earnings • Feb 26Full year 2020 earnings released: US$0.03 loss per share (vs US$0.055 loss in FY 2019)Full year 2020 results: Net loss: US$26.8m (loss narrowed 18% from FY 2019). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings.
Analyst Estimate Surprise Post Earnings • Feb 26Revenue and earnings miss expectationsRevenue missed analyst estimates by 3.8%. Earnings per share (EPS) also missed analyst estimates by 16%. Over the next year, revenue is forecast to grow 357%, compared to a 235% growth forecast for the Electronic industry in Norway.
Is New 90 Day High Low • Feb 22New 90-day high: kr3.33The company is up 70% from its price of kr1.95 on 24 November 2020. The Norwegian market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 27% over the same period.
Is New 90 Day High Low • Dec 28New 90-day high: kr3.10The company is up 49% from its price of kr2.08 on 29 September 2020. The Norwegian market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 7.0% over the same period.